Diamond-Blackfan anemia, ribosome and erythropoiesis;L'anémie de Blackfan-Diamond, ribosome et érythropoïèse

Transfusion Clinique et Biologique

Volumn 17, Issue 3, 2010, Pages 112-119

  Da Costa, L ^a,b,c   Moniz, H ^b   Simansour, M ^a   Tchernia, G ^d   Mohandas, N ^e   Leblanc, T ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b Universite Paris Sud   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d Centre d'Information et de Dépistage de la Drépanocytose   (France)

^e NEW YORK BLOOD CENTER   (United States)

Author keywords

Apoptosis; Diamond Blackfan anemia; Erythroblastopenia; P53; Ribosome

Indexed keywords

CYCLOSPORIN; DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; FERRITIN; INTERLEUKIN 3; LEUCINE; METOCLOPRAMIDE; PREDNISONE; RIBOSOME PROTEIN; RIBOSOME PROTEIN S19; RITUXIMAB; UNCLASSIFIED DRUG; VALPROIC ACID;

BLACKFAN DIAMOND ANEMIA; BLOOD TRANSFUSION; BONE MARROW DEPRESSION; BONE MARROW TRANSPLANTATION; CHROMOSOME TRANSLOCATION X; DOMINANT INHERITANCE; ERYTHROBLASTOPENIA; ERYTHROPOIESIS; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOSITY; HUMAN; LEUKOCYTE COUNT; MACROCYTIC ANEMIA; NEUTROPENIA; NONHUMAN; PATHOPHYSIOLOGY; RIBOSOME; SHORT SURVEY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOSIS;

EID: 77955853109     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2010.06.001     Document Type: Short Survey

References (88)

1. Josephs H.W. Anaemia of infancy and early childhood. Medicine 1936, 15:307-451.
2. Diamond L.K., Blackfan K.D. Hypoplastic anemia. Am J Dis Child 1938, 56:464-467.
3. Willig T.N., Niemeyer C., Leblanc T., Tiemann C., Robert A., Budde J., et al. Diamond-Blackfan anemia: clinical and epidemiological studies with identification of new long-term prognosis factors from the analysis of a registry of 234 patients. Pediatr Res 1999, 46:553-561.
4. Glader B.E., Backer K. Elevated red cell adenosine deaminase activity: a marker of disordered erythropoiesis in Diamond-Blackfan anaemia and other haematologic diseases. Br J Haematol 1988, 68:165-168.
5. Willig T.N., Pérignon J.L., Gustavsson P., Gane P., Draptchinskaya N., Testard H., et al. High adenosine deaminase level among healthy probands of Diamond-Blackfan Anemia (DBA) cosegregates with the DBA gene region on chromosome 19q13. Blood 1998, 92:4422-4427.
6. Lipton J.M., Atsidaftos E., Zyskind I., Vlachos A. Improving clinical care and elucidating the pathophysiology of Diamond-Blackfan anemia: an update from the Diamond-Blackfan anemia registry. Pediatr Blood Cancer 2005, 46:558-564.
7. Lipton J.M., Ellis S.R. Diamond-Blackfan anemia: diagnosis, treatment, and molecular pathogenesis. Hematol Oncol Clin North Am 2009, 23(2):261-282.
8. Vlachos A., Klein G.W., Lipton J.M. The Diamond-Blackfan anemia registry: tool for investigating the epidemiology and biology of Diamond-Blackfan anemia. J Pediatr Hematol Oncol 2001, 23:377-382.
9. Orfali K., Ohene-Abuakwa Y., Ball S. Diamond-Blackfan anaemia in the UK: clinical and genetic heterogeneity. Br J Haematol 2004, 125:243-252.
10. Chen S., Warszawski J., Bader-Meunier B., Tchernia G., Da Costa L., Marie I., et al. Diamond-Blackfan anemia and growth status: the French registry. J Pediatr 2005, 147:669-673.
11. Vlachos A., Ball S., Dahl N., Alter B.P., Sheth S., Ramenghi U., et al. Diagnosing and treating Diamond-Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol 2008, 142(6):859-876.
12. Porter J., Galanello R., Saglio G., Neufeld E.J., Vichinsky E., Cappellini M.D., et al. Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-year prospective study. Eur J Haematol 2008, 80(2):168-176.
13. Anderson L.J., Holden S., Davis B., Prescott E., Charrier C.C., Bunce N.H., et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001, 22(23):2171-2179.
14. Abkowitz J.L., Schaison G., Boulad F., Brown D.L., Buchanan G.R., Johnson C., et al. Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis. Blood 2002, 100:2687-2691.
15. Akiyama M., Yanagisawa T., Yuza Y., Yokoi K., Ariga M., Fujisawa K., et al. Successful treatment of Diamond-Blackfan anemia with metoclopramide. Am J Hematol 2005, 78:295-298.
16. Leblanc T.M., Da Costa L., Marie I., Demolis P., Tchernia G. Metoclopramide treatment in DBA patients: no complete response in a French prospective study. Blood 2007, 109(5):2266-2267.
17. Ball S., Tchernia G., Wranne L., Bastion Y., Bekassy N.A., Bordigoni P., et al. Is there a role for interleukine-3 in Diamond-Blackfan anaemia? Results of a european multicentre study. Br J Haematol 1995, 91:313-318.
18. El-Beshlawy A., Ibrahim I.Y., Rizk S., Eid K. Study of 22 egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results. Pediatrics 2002, 110:1-5.
19. Jabr F.L., Aoun E., Azar C., Taher A. Diamond-Blackfan anemia responding to valproic acid. Blood 2004, 104:3415.
20. Morimoto A., Kuriyama K., Tsuji K., Isoda K., Hibi S., Todo S., et al. Use of rituximab to treat refractory Diamond-Blackfan anemia. Eur J Haematol 2005, 74:442-444.
21. Pospisilova D., Cmejlova J., Hak J., Adam T., Cmejla R. Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine. Haematologica 2007, 92(5):e66-e67.
22. Cmejlova J., Dolezalova L., Pospisilova D., Petrtylova K., Petrak J., Cmejla R. Translational efficiency in patients with Diamond-Blackfan anemia. Haematologica 2006, 91(11):1456-1464.
23. Flygare J., Olsson K., Richter J., Karlsson S. Gene therapy of Diamond-Blackfan anemia CD34(+) cells leads to improved erythroid development and engraftment following transplantation. Exp Hematol 2008, 36(11):1428-1435.
24. Hamaguchi I., Flygare J., Nishiura H., Bun A.C.M., Ooka A., Kiefer T., et al. Proliferation deficiency of multipotent hematopoietic progenitors in Ribosomal Protein S19 (RPS19)-deficient Diamond-Blackfan anemia improves following RPS19 gene transfer. Mol Ther 2003, 7:613-622.
25. Hamaguchi I., Ooka A., Brun A., Richter J., Dahl N., Karlsson S. Gene transfer improves erythroid development in ribosomal protein S19-deficient Diamond-Blackfan anemia. Blood 2002, 100:2724-2731.
26. Lipton J.M., Federman N., Khabbaze Y. Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan anemia registry. J Pediatr Hematol Oncol 2001, 23:39-44.
27. Faivre L., Meerpohl J., Da Costa L., Marie I., Nouvel C., Gnekow A., et al. High-risk pregnancies in Diamond-Blackfan anemia: a survey of 64 pregnancies from the French and German registries. Haematologica 2006, 91:530-533.
28. Gustavsson P., Skeppner G., Johansson B., Berg T., Gordon L., Kreuger A., et al. Diamond-Blackfan anaemia in a girl with a de novo balanced reciprocal X;19 translocation. J Med Genet 1997, 34:779-782.
29. Draptchinskaia N., Gustavsson P., Andersson B., Pettersson M., Willig T.N., Dianzani I., et al. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet 1999, 21:169-175.
30. Ball S., Orfali K. Molecular diagnosis of Diamond-Blackfan anemia. Methods Mol Med 2004, 91:19-30.
31. Campagnoli M.F., Ramenghi U., Armiraglio M., Quarello P., Garelli E., Carando A., et al. RPS19 mutations in patients with Diamond-Blackfan anemia. Hum Mutat 2008, 29(7):911-920.
32. Cmejla R., Blafkova J., Stopka T., Zavadil J., Pospisilova D., Mihal V., et al. Ribosomal protein S19 gene mutations in patients with Diamond-Blackfan anemia and identification of ribosomal protein S19 pseudogenes. Blood Cells Mol Dis 2000, 26:124-132.
33. Ramenghi U., Campagnoli M.F., Garelli E., Carando A., Brusco A., Bagnara G.P., et al. Diamond-Blackfan anemia: report of seven further mutations in the RPS19 gene and evidence of mutation heterogeneity in the Italian population. Blood Cells Mol Dis 2000, 26(5):417-422.
34. Willig T.N., Draptchinskaia N., Dianzani I., Ball S., Niemeyer C., Ramenghi U., et al. Mutations in Ribosomal protein S19 gene and Diamond-Blackfan anemia: wide variations in phenotypic expression. Blood 1999, 94:4294-4306.
35. Proust A., Da Costa L., Rince P., Landois A., Tamary H., Zaizov R., et al. Ten novel Diamond-Blackfan anemia mutations and three polymorphisms within the rps19 gene. Hematol J 2003, 4(2):132-136.
36. Cretien A., Proust A., Delaunay J., Rince P., Leblanc T., Ducrocq R., et al. Genetic variants in the noncoding region of RPS19 gene in Diamond-Blackfan anemia: potential implications for phenotypic heterogeneity. Am J Hematol 2010, 85(2):111-116.
37. Da Costa L., Narla G., Willig T.N., Peters J., Parra M., Fixler J., et al. Ribosomal protein S19 expression during erythroid differentiation. Blood 2003, 101:318-324.
38. Soulet F., Al Saati T., Roga S., Amalric F., Bouche G. Fibroblast growth factor-2 interacts with free ribosomal protein S19. Biochem Biophys Res Commun 2001, 289:591-596.
39. Chiocchetti A., Gibello L., Carando A., Aspesi A., Secco P., Garelli E., et al. Interactions between RPS19, mutated in Diamond-Blackfan anemia, and the PIM-1 oncoprotein. Haematologica 2005, 90:1453-1462.
40. Maeda N., Toku S., Kenmochi N., Tanaka T. A novel nucleolar protein interacts with ribosomal protein S19. Biochem Biophys Res Commun 2005, 339:41.
41. Da Costa L., Tchernia G., Gascard P., Lo A., Meerpohl J., Niemeyer C., et al. Nucleolar localization of RPS19 protein in normal cells and mislocalization due to mutations in the nucleolar localization signals in two Diamond-Blackfan anemia patients: potential insights into pathophysiology. Blood 2003, 101:5039-5045.
42. Gregory L.A., Aguissa-Toure A.H., Pinaud N., Legrand P., Gleizes P.E., Fribourg S. Molecular basis of Diamond-Blackfan anemia: structure and function analysis of RPS19. Nucleic Acids Res 2007, 35:5913-5921.
43. Gazda H., Grabowska A., Merida-Long L.B., Latawiec E., Schneider H.E., Lipton J.M., et al. Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am J Hum Genet 2006, 79:1110-1118.
44. Gazda H.T., Sheen M.R., Vlachos A., Choesmel V., O'Donohue M.F., Schneider H., et al. Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am J Hum Genet 2008, 83(6):769-780.
45. Doherty L., Sheen M.R., Vlachos A., Choesmel V., O'Donohue M.F., Clinton C., et al. Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia. Am J Hum Genet 2010, 86(2):222-228.
46. Cmejla R., Cmejlova J., Handrkova H., Petrak J., Pospisilova D. Ribosomal protein S17 gene (RPS17) is mutated in Diamond-Blackfan anemia. Hum Mutat 2007, 28(12):1178-1182.
47. Farrar J.E., Nater M., Caywood E., McDevitt M.A., Kowalski J., Takemoto C.M., et al. Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia. Blood 2008, 112(5):1582-1592.
48. Quarello P., Garelli E., Carando A., Brusco A., Calabrese R., Dufour C., et al. Diamond-Blackfan anemia: genotype-phenotype correlation in Italian patients with RPL5 and RPL11 mutations. Haematologica 2010, 95(2):206-213.
49. Cmejla R., Cmejlova J., Handrkova H., Petrak J., Petrtylova K., Mihal V., et al. Identification of mutations in the ribosomal protein L5 (RPL5) and ribosomal protein L11 (RPL11) genes in Czech patients with Diamond-Blackfan anemia. Hum Mutat 2009, 30(3):321-327.
50. Léger-Silvestre I., Caffrey J.M., Dawaliby R., Alehandrovna Alvarez-Arias D., Gas N., Bertolone S.J., et al. Specific role for yeast homologs of the Diamond-Blackfan anemia-associated Rps19 protein in ribosome synthesis. J Biol Chem 2005, 280:38177-38185.
51. Choesmel V., Bacqueville D., Rouquette J., Noaillac-Depeyre J., Fribourg S., Crétien A., et al. Impaired ribosome biogenesis in Diamond-Blackfan anemia. Blood 2007, 109:1275-1283.
52. Choesmel V., Fribourg S., Aguissa-Toure A.H., Pinaud N., Legrand P., Gazda H.T., et al. Mutation of ribosomal protein RPS24 in Diamond-Blackfan anemia results in a ribosome biogenesis disorder. Hum Mol Genet 2008, 17(9):1253-1263.
53. Aguissa-Touré A.H., Da Costa L., Leblanc T., Tchernia G., Fribourg S., Gleizes P.E. Diamond-Blackfan anemia reveals the dark side of ribosome biogenesis. Med Sci (Paris) 2009, 25(1):69-76.
54. Narla A., Ebert B.L. Ribosomopathies: human disorders of ribosome dysfunction. Blood 2010, 115(16):3196-3205.
55. Ebert B.L., Pretz J., Bosco J., Chang C.Y., Tamayo P., Galili N., et al. Identification of RPS14 as a 5q-syndrome gene by RNA interference screen. Nature 2008, 451(7176):335-339.
56. Tsai P.H., Arkin S., Lipton J.M. An intrinsic progenitor defect in Diamond-Blackfan anaemia. Br J Haematol 1989, 73(1):112-120.
57. Lipton J.M., Kudisch M., Gross R., Nathan D.G. Defective erythroid progenitor differentiation system in congenital hypoplastic (Diamond-Blackfan) anemia. Blood 1986, 67:962-968.
58. Halperin D.S., Freedman M.H. Diamond-blackfan anemia: etiology, pathophysiology, and treatment. Am J Pediatr Hematol Oncol 1989, 11(4):380-394.
59. Ohene-Abuakwa Y., Orfali K.A., Marius C., Ball S.E. Two-phase culture in Diamond-Blackfan anemia: localization of erythroid defect. Blood 2004, 105:838-846.
60. Casadevall N., Croisille L., Auffray I., Tchernia G., Coulombel L. Age-related alterations in erythroid and granulopoietic progenitors in Diamond-Blackfan anaemia. Br J Haematol 1994, 87(2):369-375.
61. Santucci M.A., Bagnara G.P., Strippoli P., Bonsi L., Vitale L., Tonelli R., et al. Long-term bone marrow cultures in Diamond-Blackfan anemia reveal a defect of both granulomacrophage and erythroid progenitors. Exp Hematol 1999, 27(1):9-18.
62. Marsh J.C.W., McGuckin C.P. Cytokine stimulation of Diamond-Blackfan anaemia bone marrow. Int J Pediatr Hematol Oncol 1998, 6:309-315.
63. McGuckin C.P., Ball S.E., Gordon-Smith E.C. Diamond-Blackfan anaemia: three patterns of in vitro response to haemopoietic growth factors. Br J Haematol 1995, 89(3):457-464.
64. Giri N., Kang E., Tisdale J.F., Follman D., Rivera M., Schwartz G.N., et al. Clinical and laboratory evidence for a trilineage haematopoietic defect in patients with refractory Diamond-Blackfan anaemia. Br J Haematol 2000, 108(1):167-175.
65. Kalmanti M., Kalmantis T., Dimitriou H., Kattamis C. Correlation of in vitro enhancement of erythropoiesis and clinical response to steroids in Diamond-Blackfan anaemia. Haematologia (Budap) 1993, 25(4):263-269.
66. Freedman M.H., Amato D., Saunders E.F. Erythroid colony growth in congenital hypoplastic anemia. J Clin Invest 1976, 57(3):673-677.
67. Perdahl E.B., Naprstek B.L., Wallace W.C., Lipton J.M. Erythroid failure in Diamond-Blackfan anaemia is characterised by apoptosis. Blood 1994, 83:645-650.
68. Miyake K., Utsugisawa T., Flygare J., Kiefer T., Hamaguchi I., Richter J., et al. Ribosomal protein S19 deficiency leads to reduced proliferation and increased apoptosis but does not affect terminal erythroid differentiation in a cell line model of Diamond-Blackfan anemia. Stem Cells 2008, 26(2):323-329.
69. Gazda H., Kho A.T., Sanoudou D., Zaucha J.M., Kohane I.S., Sieff C., et al. Defective ribosomal protein gene expression alters transcription, translation, apoptosis, and oncogenic pathways in Diamond-Blackfan anemia. Stem Cells 2006, 24:2034-2044.
70. Lambertsson A. The minute genes in Drosophila and their molecular functions. Adv Genet 1998, 38:69-134.
71. Saeboe-Larssen S., Lyamouri M., Merriam J., Oksvold M.P., Lambertsson A. Ribosomal protein insufficiency and the minute syndrome in Drosophila: a dose-response relationship. Genetics 1998, 148(3):1215-1224.
72. Kongsuwan K., Yu Q., Vincent A., Frisardi M.C., Rosbash M., Lengyel J.A., et al. A Drosophila Minute gene encodes a ribosomal protein. Nature 1985, 317(6037):555-558.
73. Matsson H., Davey E., Draptchinskaia N., Hamaguchi I., Ooka A., Leveen P., et al. Targeted disruption of the ribosomal protein S19 gene is lethal prior to implantation. Mol Cell Biol 2004, 24:4032-4037.
74. Danilova N., Sakamoto K.M., Lin S. Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family. Blood 2008, 112(13):5228-5237.
75. Chakraborty A., Uechi T., Higa S., Torihara H., Kenmochi N. Loss of ribosomal protein L11 affects zebrafish embryonic development through a p53-dependent apoptotic response. PLoS One 2009, 4(1):e4152.
76. McGowan K.A., Li J.Z., Park C.Y., Beaudry V., Tabor H.K., Sabnis A.J., et al. Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat Genet 2008, 40(8):963-970.
77. Devlin E.E., Da Costa L., Narla M., Elliott G., Bodine D.M. A mouse model for Diamond-Blackfan anemia demonstrates a dominant negative effect of a point mutation in the RPS19 gene. Blood 2008, #4085.
78. Danilova N., Sakamoto K.M., Lin S. Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family. Blood 2008, 112(13):5228-5237.
79. Fumagalli S., Di Cara A., Neb-Gulati A., Natt F., Schwemberger S., Hall J., et al. Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat Cell Biol 2009, 11(4):501-508.
80. Bhat K.P., Itahana K., Jin A., Zhang Y. Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation. Embo J 2004, 23(12):2402-2412.
81. Dai M.S., Zeng S.X., Jin Y., Sun X.X., David L., Lu H. Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol 2004, 24(17):7654-7668.
82. Dai M.S., Lu H. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J Biol Chem 2004, 279(43):44475-44482.
83. Dai M.S., Shi D., Jin Y., Sun X.X., Zhang Y., Grossman S.R., et al. Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism. J Biol Chem 2006, 281(34):24304-24313.
84. Jin A., Itahana K., O'Keefe K., Zhang Y. Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol Cell Biol 2004, 24(17):7669-7680.
85. Lohrum M.A., Ludwig R.L., Kubbutat M.H., Hanlon M., Vousden K.H. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 2003, 3(6):577-587.
86. Marechal V., Elenbaas B., Piette J., Nicolas J.C., Levine A.J. The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol Cell Biol 1994, 14(11):7414-7420.
87. Zhang Y., Wolf G.W., Bhat K., Jin A., Allio T., Burkhart W.A., et al. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol 2003, 23(23):8902-8912.
88. Moniz H., Hurtaud C., Leblanc T., Tchernia G., Narla M., Da Costa L. Distinct differences in in vitro erythroid proliferation and differentiation, p53 and apoptosis pathways in Diamond-Blackfan anemia in conjunction with different RPS19 mutations. Blood (ASH meeting abstract) 2009, 114:176.